Susceptibility of Haemophilus influenzae to chloramphenicol and eight beta-lactam antibiotics.

Antimicrobial Agents and Chemotherapy
M C ThirumoorthiA S Dajani

Abstract

We examined the minimal inhibitory concentrations and minimal bactericidal concentrations of chloramphenicol, ampicillin, ticarcillin, cefamandole, cefazolin, cefoxitin, cefotaxime, ceforanide, and moxalactam for 100 isolates of Haemophilus influenzae, 25 of which produced beta-lactamase. Susceptibility was not influenced by the capsular characteristic of the organism. The mean minimal inhibitory concentrations of cefamandole, ticarcillin, and ampicillin for beta-lactamase-producing strains were 3-, 120-, and 400-fold higher than their respective mean minimal inhibitory concentrations for beta-lactamase-negative strains. No such difference was noted for the other antibiotics. We performed time-kill curve studies, using chloramphenicol, ampicillin, cefamandole, cefotaxime, and moxalactam with two concentrations of the antimicrobial agents (4 or 20 times the minimal inhibitory concentrations) and two inoculum sizes (10(4) or 10(6) colony-forming units per ml). The inoculum size had no appreciable effect on the rate of killing of beta-lactamase-negative strains. The rates at which beta-lactamase-producing strains were killed by chloramphenicol, cefotaxime, and moxalactam was not influenced by the inoculum size. Whereas cefamandole...Continue Reading

References

Jul 1, 1978·American Journal of Diseases of Children·W E Feldman
May 1, 1978·Antimicrobial Agents and Chemotherapy·W Fleming, J Fierer
Oct 1, 1979·Antimicrobial Agents and Chemotherapy·V P SyriopoulouA L Smith
Nov 1, 1977·The Journal of Pediatrics·M Santosham, E R Moxon
Dec 1, 1979·The Journal of Pediatrics·C A FriedmanA L Smith
Jul 1, 1978·Antimicrobial Agents and Chemotherapy·N AswapokeeH C Neu
Jun 11, 1976·The Journal of Infectious Diseases·W E Farrar, P K Gramling
Jan 1, 1976·Antimicrobial Agents and Chemotherapy·C ThornsberryJ M Swenson
Jan 12, 1980·Lancet·B H BelohradskyG Peters

❮ Previous
Next ❯

Citations

Feb 1, 1984·Antimicrobial Agents and Chemotherapy·S SirinavinS Lolekha
Apr 1, 1988·Clinical Microbiology Reviews·C A Needham

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.